A Child with Local Lipohypertrophy following Recombinant Human Growth Hormone Administration
Local lipohypertrophy due to recombinant human growth hormone (rhGH) administration is a rare phenomenon. Here, we report a case of an 11-year-old girl who presented with a paraumbilical swelling, approximately one year after the start of rhGH treatment for short stature due to the presumed diagnosi...
Main Authors: | Ilan J. N. Koppen, Roel Bakx, Chris C. de Kruiff, A. S. Paul van Trotsenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2016/9648043 |
Similar Items
-
Insulin lipodystrophy and lipohypertrophy
by: Jatinder K Mokta, et al.
Published: (2013-01-01) -
Lipohypertrophy: prevalence, clinical consequence, and pathogenesis
by: Xiao-Han Xu, et al.
Published: (2021-01-01) -
Prediction of lipohypertrophy in patients with diabetes mellitus
by: V Brijeetha, et al.
Published: (2020-01-01) -
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
by: Vadim V. Klimontov, et al.
Published: (2018-10-01) -
Factors Associated with Lipohypertrophy in Diabetic Patients with Insulin Therapy
by: Su-Ying Yen, et al.
Published: (2018)